150 related articles for article (PubMed ID: 22878250)
1. A mixed infection of Leuconostoc lactis and vancomycin-resistant Enterococcus in a liver transplant recipient.
Deng Y; Zhang Z; Xie Y; Xiao Y; Kang M; Fan H
J Med Microbiol; 2012 Nov; 61(Pt 11):1621-1624. PubMed ID: 22878250
[TBL] [Abstract][Full Text] [Related]
2. Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case report.
Swoboda S; Fritz S; Martignoni ME; Feldhues RA; Hoppe-Tichy T; Buchler MW; Geiss HK
J Antimicrob Chemother; 2005 Oct; 56(4):787-9. PubMed ID: 16143710
[TBL] [Abstract][Full Text] [Related]
3. [A case of vancomycin resistant Leuconostoc meningitis].
Hatipoğlu CA; Yildiz E; Köktekir E; Ipekkan K; Karakoç EA; Demiröz AP
Mikrobiyol Bul; 2008 Oct; 42(4):695-9. PubMed ID: 19149094
[TBL] [Abstract][Full Text] [Related]
4. Treatment options for vancomycin-resistant enterococcal infections.
Linden PK
Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of linezolid in liver transplant patients.
Radunz S; Juntermanns B; Kaiser GM; Treckmann J; Mathe Z; Paul A; Saner FH
Transpl Infect Dis; 2011 Aug; 13(4):353-8. PubMed ID: 21355969
[TBL] [Abstract][Full Text] [Related]
6. Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium.
Herrero IA; Issa NC; Patel R
N Engl J Med; 2002 Mar; 346(11):867-9. PubMed ID: 11893808
[No Abstract] [Full Text] [Related]
7. Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid.
Hachem R; Afif C; Gokaslan Z; Raad I
Eur J Clin Microbiol Infect Dis; 2001 Jun; 20(6):432-4. PubMed ID: 11476449
[No Abstract] [Full Text] [Related]
8. First report of a linezolid- and vancomycin-resistant Enterococcus faecium strain in Korea.
Bae HG; Sung H; Kim MN; Lee EJ; Koo Lee S
Scand J Infect Dis; 2006; 38(5):383-6. PubMed ID: 16709544
[TBL] [Abstract][Full Text] [Related]
9. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study.
Crank CW; Scheetz MH; Brielmaier B; Rose WE; Patel GP; Ritchie DJ; Segreti J
Clin Ther; 2010 Sep; 32(10):1713-9. PubMed ID: 21194593
[TBL] [Abstract][Full Text] [Related]
10. Endocarditis due to vancomycin-resistant Enterococcus raffinosus successfully treated with linezolid: case report and review of literature.
Jasovich A; Ganaha MC; Ebi C; García RD; Blanco MA; Lopardo H
Rev Argent Microbiol; 2008; 40(4):204-7. PubMed ID: 19213241
[TBL] [Abstract][Full Text] [Related]
11. Differences in clinical outcomes in patients with vancomycin-resistant enterococci according to linezolid susceptibility.
Scheetz MH; Knechtel SA; Postelnick MJ; Malczynski M; Qi C
Pharmacotherapy; 2010 Dec; 30(12):1221-8. PubMed ID: 21114389
[TBL] [Abstract][Full Text] [Related]
12. [In vitro activity of linezolid and dalbavancin against vancomycin-resistant enterococci].
Aktaş G; Bozdoğan B; Derbentli S
Mikrobiyol Bul; 2012 Jul; 46(3):359-65. PubMed ID: 22951648
[TBL] [Abstract][Full Text] [Related]
13. Predictors and outcomes of linezolid-resistant vancomycin-resistant Enterococcus: a case-case-control study.
Hayakawa K; Marchaim D; Pogue JM; Ho K; Parveen S; Nanjireddy P; Sunkara B; Singla M; Jagadeesh KK; Moshos JA; Bommarito S; Mroue R; Farhat M; Obeid T; Chaudhry A; Vadlamudi G; Lephart PR; Martin ET; Rybak MJ; Kaye KS
Am J Infect Control; 2012 Dec; 40(10):e261-3. PubMed ID: 23199727
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of vancomycin-resistant Enterococcus faecium endocarditis with linezolid in a renal transplant recipient with human immunodeficiency virus infection.
Archuleta S; Murphy B; Keller MJ
Transpl Infect Dis; 2004 Sep; 6(3):117-9. PubMed ID: 15569227
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin-resistant enterococcal meningitis in an autologous stem cell transplant recipient cured with linezolid.
Frasca KL; Schuster MG
Transpl Infect Dis; 2013 Feb; 15(1):E1-4. PubMed ID: 23173835
[TBL] [Abstract][Full Text] [Related]
16. Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium.
Till M; Wixson RL; Pertel PE
Clin Infect Dis; 2002 May; 34(10):1412-4. PubMed ID: 11981739
[TBL] [Abstract][Full Text] [Related]
17. Linezolid treatment of vancomycin-resistant Enterococcus faecium ventriculitis.
Graham PL; Ampofo K; Saiman L
Pediatr Infect Dis J; 2002 Aug; 21(8):798-800. PubMed ID: 12233719
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid.
Babcock HM; Ritchie DJ; Christiansen E; Starlin R; Little R; Stanley S
Clin Infect Dis; 2001 May; 32(9):1373-5. PubMed ID: 11303275
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and outcomes associated with vancomycin-resistant Enterococcus infections with reduced susceptibilities to linezolid.
Santayana EM; Grim SA; Janda WM; Layden JE; Lee TA; Clark NM
Diagn Microbiol Infect Dis; 2012 Sep; 74(1):39-42. PubMed ID: 22749382
[TBL] [Abstract][Full Text] [Related]
20. A therapeutic benefit of daptomycin against glycopeptide-resistant gram-positive cocci bloodstream infections under neutropenia.
Matsuda K; Koya J; Toyama K; Ikeda M; Arai S; Nakamura F; Okugawa S; Moriya K; Kurokawa M
J Infect Chemother; 2017 Nov; 23(11):788-790. PubMed ID: 28743428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
